RTNB yields 2000000.00% · PFE yields 6.20%● Live data
📍 RTNB pulled ahead of the other in Year 1
Combined, RTNB + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RTNB + PFE for your $10,000?
root9B Holdings, Inc. provides cybersecurity and business advisory services primarily in regulatory risk mitigation in the United States and internationally. The company's Cyber Solutions segment offers cyber security, advanced technology training, operational support, and consulting services. This segment provides cyber operations assessments, analysis and testing, cyber training, forensics, exploitation, and strategic defense planning services. Its Business Advisory Solutions segment offers anti-money laundering (AML) operational, investigative, and remediation services, as well as AML risk advisory and consulting services in the areas of risk, data, organizational change, and cyber. This segment also conducts high-end investigations with expertise in services ranging from complex financial crime and intellectual property issues to conduct anti-bribery investigations or due diligence on a potential partner or customer. root9B Holdings, Inc. serves Fortune 500 companies, medium-sized businesses, and governmental entities. The company was formerly known as root9B Technologies, Inc. and changed its name to root9B Holdings, Inc. in December 2016. root9B Holdings, Inc. was founded in 1995 and is based in Phoenix, Arizona.
Full RTNB Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.